Atle Fund Management AB

Holdings as of 2026-06-30, filed 2026-07-24 · recorded 2026-07-26 16:40:33.204 UTC

This is history, not a current position. These holdings describe 2026-06-30, and the report became public 24 days later. The portfolio has changed since.

Aggregates

computed from the positions below
Positions reported
39
Value reported by manager
$371.7M
Sum of our stored positions
$371.7M
should match the line above
Disclosure lag
24 d
quarter end to filing
Top 5 concentration
30.4%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls

Positions

39 largest shown
IssuerClassValueSharesTypeCUSIP
ELI LILLY & COCOM$35.8M29,821—532457108
MERCK & CO. INCCOM$24.3M189,357—58933Y105
JOHNSON & JOHNSONCOM$21.7M85,425—478160104
ABBVIE INCCOM$16.2M64,325—00287Y109
CVS HEALTH CORPCOM$15.1M146,102—126650100
THERMO FISHER SCIENTIFIC CORPCOM$14M27,859—883556102
REVOLUTION MEDICINES INCCOM$13.7M73,077—76155X100
BIOGEN INCCOM$13.6M62,781—09062X103
NEUROCRINE BIOSCIENCES INCCOM$12.3M72,898—64125C109
MIRUM PHARMACEUTICALS INCCOM$11.8M100,807—604749101
ALKERMES PLCSHS$11.2M213,329—G01767105
IONIS PHARMACEUTICALS INCCOM$10.9M137,131—462222100
BEONE MEDICINES LTD-ADRSPONSORED ADS$10M35,180—07725L102
INTUITIVE SURGICAL INCCOM NEW$9.8M24,656—46120E602
STRYKER CORPORATIONCOM$9.5M30,283—863667101
VERTEX PHARMACEUTICALS INCCOM$9.5M19,131—92532F100
EDWARDS LIFESCIENCES CORPCOM$9.3M103,230—28176E108
BRIDGEBIO PHARMA INCCOM$9.3M124,707—10806X102
KRYSTAL BIOTECH, INCCOM$8.9M24,019—501147102
CENCORA INCCOM$8.8M31,126—03073E105
NEWAMSTERDAM PHARMA CO NVORDINARY SHARES$8.4M248,848—N62509109
ABIVAX SASPONSORED ADS$7.8M58,170—00370M103
INCYTE CORPCOM$6.5M56,953—45337C102
IRHYTHM TECHNOLOGIES INCCOM$6.4M54,102—450056106
BOSTON SCIENTIFCCOM$6.2M146,381—101137107
INSMED INCCOM PAR $.01$6.2M58,378—457669307
TANGO THERAPEUTICS INCCOM$6.2M198,557—87583X109
GILEAD SCIENCES INCCOM$5.8M46,142—375558103
CARDINAL HEALTH INCCOM$5.6M23,630—14149Y108
ORUKA THERAPEUTICOM$5.2M54,886—687604108
SPYRE THERAPEUTICS INCCOM NEW$5.1M57,030—00773J202
DEXCOM INCCOM NEW$4.8M71,846—252131107
BICARA THERAPEUTICS INCCOM$4.3M145,657—055477103
IDEAYA BIOSCIENCES INCCOM$3.5M94,478—45166A102
CELCUITY INCCOM$3.5M33,313—15102K100
DISC MEDICINE INCCOM$3.2M43,682—254604101
PYXIS ONCOLOGY INCCOMMON STOCK$2.9M966,459—747324101
COMPASS THERAPEUTICS INCCOM$2.3M1,048,593—20454B104
JADE BIOSCIENCESCOM NEW$2M88,556—008064206
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.

Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-07-24